Test your blood for any biomarker at any time with just a fingerprick.
Ferry Lifesciences is developing an IoT-enabled, multiplexed, modular, microfluidic, point-of-care diagnostic platform. This pioneering technology allows individuals to take control of their health by performing multiple blood tests simultaneously using only microliters of blood and utilizing real biomarkers instead of proxies often used by wearables or non-invasive diagnostics.
1. TIDE 2.0 Grant by MeITy: Centre for Cellular and Molecular Biology, Hyderabad.2. Titanium Grant by SINE: Indian Institute of Technology, Bombay.3. Longevity India Grant by FSID and Rainmatter (Zerodha): Indian Institute of Science, Bengaluru. Total funding in grants is 70 Lakhs INR.
Two patents have been filed (IIT-Bombay), along with multiple invention disclosure forms. Ongoing research and development is being conducted for further assays in the field of point-of-care diagnostics and microfluidics.
1. National winners of RISE Ideathon, Longevity India. 2. PHIxAI HealthOn Challenge global winners.
A lean team of three founders with medical training from AFMC and design/engineering talent from IIT-Bombay and IIT-Guwahati, bringing extensive industry experience in health technology and senior roles in post Series A-funded startups.
Chief Scientific Officer
Chief Executive Officer
Chief Technology Officer
Design Lead
